DETERMATX

Serial Number 88682865
606

Registration Progress

Application Filed
Nov 6, 2019
Under Examination
May 5, 2020
Approved for Publication
Mar 10, 2020
Published for Opposition
Mar 10, 2020
Registered

Trademark Image

DETERMATX

Basic Information

Serial Number
88682865
Filing Date
November 6, 2019
Published for Opposition
March 10, 2020
Abandonment Date
June 5, 2023
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 5, 2023
Classes
001 005 010 042

Rights Holder

OncoCyte Corporation

03
Address
15 Cushing
Irvine, CA 92618

Ownership History

OncoCyte Corporation

Original Applicant
03
Alameda, CA

OncoCyte Corporation

Owner at Publication
03
Irvine, CA

Legal Representation

Attorney
Christopher D. Olszyk, Jr.

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

34 events
Date Code Type Description Documents
Jun 5, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jun 5, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Nov 8, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 7, 2022 EX5G S SOU EXTENSION 5 GRANTED Loading...
Nov 7, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 31, 2022 EXT5 S SOU EXTENSION 5 FILED Loading...
Oct 31, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 28, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 26, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
Apr 26, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
Apr 26, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 27, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 25, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 25, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 25, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 21, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 19, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 19, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 19, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 7, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 5, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 5, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 5, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 17, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 17, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 17, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
May 5, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 10, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 10, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 19, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 31, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 29, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 14, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 9, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Diagnostic reagents for clinical or medical laboratory use; diagnostic reagents for scientific or research use; reagents for scientific or medical research use
Class 005
Chemical reagents for medical or veterinary purposes; clinical medical reagents; diagnostic reagents for medicinal use; medical diagnostic reagents; reagents for medical use
Class 010
Medical instruments for use in performing biopsies and medical diagnostic apparatus for testing biomarkers; cancer screening tests and devices, namely, medical devices for matching cancer diagnosis with cancer treatments; blood testing apparatus for cancer diagnosis and evaluation of treatment options; medical testing devices for tumor diagnosis and treatment evaluation
Class 042
Providing reagent sample testing and diagnostic services for others in the field of cancer testing; scientific research and analysis in the field of genetic profiling for the purpose of matching cancer diagnosis with therapeutic treatments

Classification

International Classes
001 005 010 042